在未受影响的韩国BRCA1/2突变载体中,风险降低策略的模式分析
Dabin Kim1, Jai Min Ryu2, Sang-Ah Han3
1Department of Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon 14584, Republic of Korea.
Current oncology (Toronto, Ont.)
|November 26, 2024
概括
具有BRCA1/2突变的未受影响个体具有患乳腺癌和卵巢癌的高风险. 在这个韩国队列中,监测和降低风险的干预措施显著较低,需要改善癌症预防策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 预防医学 预防医学
背景情况:
- 具有BRCA1/2突变的个体面临着显著增加的乳腺癌和卵巢癌的终身风险.
- 早期检测和预防策略对于BRCA1/2突变携带者至关重要,但对干预吸收的数据有限.
研究的目的:
- 调查癌症监测和降低风险干预措施在不受影响的韩国携带BRCA1/2突变者中的模式.
主要方法:
- 从韩国遗传性乳腺癌 (KOHBRA) 研究中确定了一组未受影响的BRCA1/2突变携带者.
- 一项电话调查评估了癌症发病率,监测模式 (乳腺,卵巢,前列腺),化疗预防,降低风险的手术和动机.
主要成果:
- 在46名参与者中 (15名男性,31名女性),平均随访时间为103个月,10人患有乳腺癌,1人患有卵巢癌,3人患有其他癌症.
- 只有19.4%的人遵守推的乳腺癌监测;卵巢和前列腺监测是不存在的.
- 有9.7%的参与者使用化疗预防,只有1名参与者使用降低风险的salpingo-oophorectomy.
结论:
- 没有受到影响的韩国BRCA1/2突变携带者表现出推的癌症监测,化疗预防和降低风险的手术的低率.
- 迫切需要加强战略,促进高风险人群积极参与降低风险的措施.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.2K
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
14.6K
相关概念视频
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Probability Laws
40.2K
Overview
40.2K
